Open access
Jul 2026
SACF and GILA for in vitro transformation assessment of CRISPR/Cas9-edited cell therapy candidates: a multi-site study.
Data establish multi-site reproducibility of SACF and GILA in the MCF10A-PTPN12 model evaluated here and support their use as animal-free, development-stage characterization tools contributing to tumorigenicity evidence generation.
Lena Dorsheimer, J. Ferreira, Bojing Wang et al.
· Gene Therapy · 0 citations